<DOC>
	<DOCNO>NCT02259218</DOCNO>
	<brief_summary>This research trial study metabolomic molecular profiling identify predictive biomarkers radiation toxicity survival patient lung brain cancer receive radiation therapy . Studying sample blood , urine , tissue patient lung brain cancer laboratory may help doctor identify learn biomarkers related cancer predict patient higher risk develop radiation side effect well patient respond radiation treatment .</brief_summary>
	<brief_title>Longitudinal Metabolomic Epigenetic Profiling Bodyfluids From Patients With Lung Brain Cancer Receiving Radiation Therapy</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I. Metabolomic epigenetic urine blood profile patient undergo radiation therapy lung cancer associate development radiation pneumonitis . II . Metabolomic epigenetic urine blood profile patient undergo radiation therapy brain cancer associate development radiation necrosis . SECONDARY OBJECTIVES : I. Metabolomic epigenetic urine , blood , tissue profile patient undergo radiation therapy lung brain cancer associate survival . OUTLINE : Collected blood , urine , tissue sample analyze biomarkers via metabolomic epigenetic profiling use massspectrometry , array , sequencing-based technology .</detailed_description>
	<criteria>Consultation Radiation Oncology department Ohio State University ( OSU ) Comprehensive Cancer Center The following diagnosis include : malignant neoplasm brain ; primary malignant neoplasm trachea bronchus lung ; primary malignant neoplasm cervix uteri primary malignant neoplasm prostate Being inmate</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Biomarker</keyword>
	<keyword>Radiation</keyword>
</DOC>